Ethan Crossfield 
If you’re deciding whether to jump into a new co-op zombie shooter on Steam—or wait for updates—Codename Cure 2 is already showing strong early momentum. The free game launched with mostly positive reviews, supports squads of up to five, and mixes procedurally generated missions with a progression loop between runs.
What launched: a free co-op zombie FPS for up to five
Codename Cure 2 released on Steam on July 24 and has already gathered over 600 user reviews, currently landing at a Mostly Positive rating (79%) based on the Steam review snapshot cited in the source. It’s a free-to-play co-op, first-person shooter built around surviving an endless horde of undead.
The core loop centers on taking on procedurally generated deployments and then returning to “Cure HQ” between missions. There, players can customize their soldier, unlock new weapons, and equip cosmetics before heading back out for the next operation. The source also highlights that the game’s fundamental “squad up and shoot zombies” premise appears to be landing with most players, particularly those who value co-op gameplay and mission variety.
Still, early feedback isn’t uniformly glowing. Reviewers point to rough visuals and inconsistent lighting, and they argue the current content breadth could be wider—specifically calling for more maps, enemies, and overall material for long-term engagement.
How players describe the experience—and what they want fixed
Beyond general praise for co-op and progression, the source includes a recurring critique: even with procedural mission design, many runs reportedly follow a similar structure. Players have noticed that missions tend to end with a short timer, a horde encounter, and an extraction, creating a “samey” feeling by the time you’ve seen multiple deployments.
That concern ties directly into the larger request for expansion. While the game already offers progression and customization, the feedback suggests it may need more variety in mission endings and more distinct content to keep sessions fresh over time. In other words, the gameplay loop works, but the repetition factor is becoming visible early.
Monetization and the roadmap: paid DLC mixed with “mostly” free updates
Because Codename Cure 2 is a free-to-play Steam title, the source notes it must monetize somehow. However, it states that monetization does not appear overly aggressive at the time of writing. Developer Raptor Byte’s stated approach is to rely primarily on paid DLC rather than heavy-handed monetization.
One paid DLC is already available, adding cosmetics, new gun sights, and the Spas 12 shotgun—meaning at least some content is currently behind a paywall. Looking ahead, a developer update (as summarized in the source) indicates future additions will be “mostly” free with some paid DLC mixed in.
Planned items include more weapons and sidearms for each class, a new game mode, 1–2 new maps, a new region for Bomb Extraction, new weapon skins, and social/quality-of-life features such as a ping or quick chat system. The roadmap also mentions additional customization options and other tweaks—aimed at addressing the same variety concerns players have raised.
What players should know
- Codename Cure 2 is free on Steam and supports co-op squads of up to five players.
- Early Steam sentiment is Mostly Positive (79%) with over 600 reviews cited in the source.
- Expect procedurally generated missions, but some players report mission endings feel repetitive.
- There is paid DLC already, including cosmetics, gun sights, and the Spas 12 shotgun.
Expert View
Codename Cure 2 looks like a solid “jump in with friends” zombie shooter with the kind of progression loop that keeps short sessions rewarding. The early review data suggests the co-op foundation is working, but the most consistent complaints—repetitive mission structure and a need for more content—are exactly the areas that determine whether a free-to-play game stays sticky. If the incoming mix of maps, weapons, modes, and quality-of-life updates lands as described, the game has a clear path to turning that early promise into longer-term retention.
